1. Home
  2. MRVI vs CFFN Comparison

MRVI vs CFFN Comparison

Compare MRVI & CFFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • CFFN
  • Stock Information
  • Founded
  • MRVI 2020
  • CFFN 1893
  • Country
  • MRVI United States
  • CFFN United States
  • Employees
  • MRVI N/A
  • CFFN N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • CFFN Savings Institutions
  • Sector
  • MRVI Health Care
  • CFFN Finance
  • Exchange
  • MRVI Nasdaq
  • CFFN Nasdaq
  • Market Cap
  • MRVI 809.2M
  • CFFN 734.6M
  • IPO Year
  • MRVI 2020
  • CFFN 1999
  • Fundamental
  • Price
  • MRVI $4.77
  • CFFN $5.72
  • Analyst Decision
  • MRVI Buy
  • CFFN Hold
  • Analyst Count
  • MRVI 10
  • CFFN 2
  • Target Price
  • MRVI $10.28
  • CFFN $6.75
  • AVG Volume (30 Days)
  • MRVI 1.8M
  • CFFN 874.1K
  • Earning Date
  • MRVI 02-25-2025
  • CFFN 01-29-2025
  • Dividend Yield
  • MRVI N/A
  • CFFN 5.94%
  • EPS Growth
  • MRVI N/A
  • CFFN N/A
  • EPS
  • MRVI N/A
  • CFFN 0.29
  • Revenue
  • MRVI $276,920,000.00
  • CFFN $166,046,000.00
  • Revenue This Year
  • MRVI N/A
  • CFFN N/A
  • Revenue Next Year
  • MRVI $2.25
  • CFFN $9.30
  • P/E Ratio
  • MRVI N/A
  • CFFN $19.72
  • Revenue Growth
  • MRVI N/A
  • CFFN N/A
  • 52 Week Low
  • MRVI $4.28
  • CFFN $4.76
  • 52 Week High
  • MRVI $11.56
  • CFFN $7.20
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 39.85
  • CFFN 33.96
  • Support Level
  • MRVI $4.38
  • CFFN $5.66
  • Resistance Level
  • MRVI $6.21
  • CFFN $5.93
  • Average True Range (ATR)
  • MRVI 0.39
  • CFFN 0.14
  • MACD
  • MRVI -0.09
  • CFFN 0.01
  • Stochastic Oscillator
  • MRVI 21.31
  • CFFN 40.00

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About CFFN Capitol Federal Financial Inc.

Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank, Capitol Federal Savings Bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It primarily serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.

Share on Social Networks: